LY2811376 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
LY2811376 is the first orally available non-peptidic BACE1 inhibitor that produces profound A??-lowering effects in animals.
More Information Supplier PageLY2811376 is the first orally available non-peptidic BACE1 inhibitor that produces profound A??-lowering effects in animals.
More Information Supplier PageLY2811376 is the first orally available non-peptidic BACE1 inhibitor that produces profound A??-lowering effects in animals.
More Information Supplier PageLY2811376 is the first orally available non-peptidic BACE1 inhibitor that produces profound A??-lowering effects in animals.
More Information Supplier PageAzilsartan (TAK-536) is an angiotensin II receptor antagonist used in the treatment of hypertension.
More Information Supplier PageAzilsartan (TAK-536) is an angiotensin II receptor antagonist used in the treatment of hypertension.
More Information Supplier PageAzilsartan (TAK-536) is an angiotensin II receptor antagonist used in the treatment of hypertension.
More Information Supplier PageSL-251188, an oxazolidinone derivative, was characterized in baboons as a radioligand for the in vivo visualization of MAO-B using positron emission tomography (PET).
More Information Supplier PageSL-251188, an oxazolidinone derivative, was characterized in baboons as a radioligand for the in vivo visualization of MAO-B using positron emission tomography (PET).
More Information Supplier PagePF 670462 inhibits PER protein nuclear translocation (EC50 = 290 nM) causing phase shifts in circadian rhythms and attenuates methamphetamine-stimulated locomotion in vivo.
More Information Supplier PagePF 670462 inhibits PER protein nuclear translocation (EC50 = 290 nM) causing phase shifts in circadian rhythms and attenuates methamphetamine-stimulated locomotion in vivo.
More Information Supplier Page